keyword
https://read.qxmd.com/read/38490717/crl4-dcaf1-ubiquitin-ligase-regulates-plk4-protein-levels-to-prevent-premature-centriole-duplication
#1
JOURNAL ARTICLE
Josina Grossmann, Anne-Sophie Kratz, Alina Kordonsky, Gali Prag, Ingrid Hoffmann
Centrioles play important roles in the assembly of centrosomes and cilia. Centriole duplication occurs once per cell cycle and is dependent on polo-like kinase 4 (PLK4). To prevent centriole amplification, which is a hallmark of cancer, PLK4 protein levels need to be tightly regulated. Here, we show that the Cullin4A/B-DDB1-DCAF1, CRL4DCAF1 , E3 ligase targets PLK4 for degradation in human cells. DCAF1 binds and ubiquitylates PLK4 in the G2 phase to prevent premature centriole duplication in mitosis. In contrast to the regulation of PLK4 by SCFβ-TrCP , the interaction between PLK4 and DCAF1 is independent of PLK4 kinase activity and mediated by polo-boxes 1 and 2 of PLK4, suggesting that DCAF1 promotes PLK4 ubiquitylation independently of β-TrCP...
June 2024: Life Science Alliance
https://read.qxmd.com/read/38363405/vegfr-affects-mir-3200-3p-mediated-regulatory-t-cell-senescence-in-tumour-derived-exosomes-in-non-small-cell-lung-cancer
#2
JOURNAL ARTICLE
Kaiyuan Hui, Changhong Dong, Chenxi Hu, Jiawen Li, Dongyue Yan, Xiaodong Jiang
Numerous studies have demonstrated that regulatory T (Treg) cells play an important role in the tumour microenvironment (TME). The aim of this study was to investigate whether VEGFR2 affects the expression of miR-3200-3p in exosomes secreted by tumour cells, thereby influencing Treg senescence in the TME. The results showed that VEGFR2 expression level was the highest in Calu-1 cells, and after transfection with si-VEGFR2, the exosomes secreted from Calu-1 cells were extracted and characterised with no significant difference from the exosomes of the untransfected group, but the expression of miR-3200-3p in the exosomes of the transfected si-VEGFR2 group was elevated...
February 16, 2024: Functional & Integrative Genomics
https://read.qxmd.com/read/38177131/dcaf1-based-protacs-with-activity-against-clinically-validated-targets-overcoming-intrinsic-and-acquired-degrader-resistance
#3
JOURNAL ARTICLE
Martin Schröder, Martin Renatus, Xiaoyou Liang, Fabian Meili, Thomas Zoller, Sandrine Ferrand, Francois Gauter, Xiaoyan Li, Frederic Sigoillot, Scott Gleim, Therese-Marie Stachyra, Jason R Thomas, Damien Begue, Maryam Khoshouei, Peggy Lefeuvre, Rita Andraos-Rey, BoYee Chung, Renate Ma, Benika Pinch, Andreas Hofmann, Markus Schirle, Niko Schmiedeberg, Patricia Imbach, Delphine Gorses, Keith Calkins, Beatrice Bauer-Probst, Magdalena Maschlej, Matt Niederst, Rob Maher, Martin Henault, John Alford, Erik Ahrne, Luca Tordella, Greg Hollingworth, Nicolas H Thomä, Anna Vulpetti, Thomas Radimerski, Philipp Holzer, Seth Carbonneau, Claudio R Thoma
Targeted protein degradation (TPD) mediates protein level through small molecule induced redirection of E3 ligases to ubiquitinate neo-substrates and mark them for proteasomal degradation. TPD has recently emerged as a key modality in drug discovery. So far only a few ligases have been utilized for TPD. Interestingly, the workhorse ligase CRBN has been observed to be downregulated in settings of resistance to immunomodulatory inhibitory drugs (IMiDs). Here we show that the essential E3 ligase receptor DCAF1 can be harnessed for TPD utilizing a selective, non-covalent DCAF1 binder...
January 4, 2024: Nature Communications
https://read.qxmd.com/read/38058430/enhanced-infection-efficiency-and-cytotoxicity-mediated-by-vpx-containing-lentivirus-in-chimeric-antigen-receptor-macrophage-car-m
#4
JOURNAL ARTICLE
Yun Gao, Yue Ju, Xiaomeng Ren, Luo Zhang, Xiushan Yin
Genetically modified macrophage infusion has been proven to be a novel treatment for cancer. One of the most important processes in macrophage-based therapy is the efficient transfer of genes. HIV-1-derived lentiviruses were widely used as delivery vectors in chimeric antigen receptor T and NK cell construction. While macrophages are relatively refractory to this lentiviral vector transduction as a result of the myeloid-specific restriction factor SAMHD1, which inhibited the virion cycle through exhausting the dNTPs pool and degradating RNAs...
December 2023: Heliyon
https://read.qxmd.com/read/37760992/vprbp-dcaf1-triggers-melanomagenic-gene-silencing-through-histone-h2a-phosphorylation
#5
JOURNAL ARTICLE
Yonghwan Shin, Sungmin Kim, Gangning Liang, Tobias S Ulmer, Woojin An
Vpr binding protein (VprBP), also known as DDB1- and CUL4-associated factor1 (DCAF1), is a recently identified atypical kinase and plays an important role in downregulating the transcription of tumor suppressor genes as well as increasing the risk for colon and prostate cancers. Melanoma is the most aggressive form of skin cancer arising from pigment-producing melanocytes and is often associated with the dysregulation of epigenetic factors targeting histones. Here, we demonstrate that VprBP is highly expressed and phosphorylates threonine 120 (T120) on histone H2A to drive the transcriptional inactivation of growth-regulatory genes in melanoma cells...
September 17, 2023: Biomedicines
https://read.qxmd.com/read/37502858/vprbp-dcaf1-triggers-melanomagenic-gene-silencing-through-histone-h2a-phosphorylation
#6
Yonghwan Shin, Sungmin Kim, Gangning Liang, Tobias S Ulmer, Woojin An
Background Melanoma is the most aggressive form of skin cancer arising from pigment-producing melanocytes and is often associated with dysregulation of epigenetic factors targeting histones. VprBP, also known as DCAF1, is a recently identified kinase and plays an important role in downregulating the transcription of tumor suppressor genes as well as increasing the risk for colon and prostate cancers. However, it remains unknown whether VprBP is also involved in triggering the pathogenesis of other types of cancer...
July 12, 2023: Research Square
https://read.qxmd.com/read/37465299/discovery-of-new-binders-for-dcaf1-an-emerging-ligase-target-in-the-targeted-protein-degradation-field
#7
JOURNAL ARTICLE
Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg, Patricia Imbach-Weese, Carole Pissot-Soldermann, Gregory J Hollingworth, Thomas Radimerski, Claudio R Thoma, Therese-Marie Stachyra, Matthias Wojtynek, Magdalena Maschlej, Suzanne Chau, Ansgar Schuffenhauer, César Fernández, Martin Schröder, Martin Renatus
In this study, we describe the rapid identification of potent binders for the WD40 repeat domain (WDR) of DCAF1. This was achieved by two rounds of iterative focused screening of a small set of compounds selected on the basis of internal WDR domain knowledge followed by hit expansion. Subsequent structure-based design led to nanomolar potency binders with a clear exit vector enabling DCAF1-based bifunctional degrader exploration.
July 13, 2023: ACS Medicinal Chemistry Letters
https://read.qxmd.com/read/37433110/the-c-elegans-crl4dcaf-1-ubiquitin-ligase-is-required-for-proper-germline-nucleolus-morphology-and-male-development
#8
JOURNAL ARTICLE
Mohammad M Rahman, Riju S Balachandran, Jonathan B Stevenson, Youngjo Kim, Rui B Proenca, Edward M Hedgecock, Edward T Kipreos
Cullin-RING ubiquitin ligases (CRLs) are the largest class of ubiquitin ligases with diverse functions encompassing hundreds of cellular processes. Inactivation of core components of the CRL4 ubiquitin ligase produces a germ cell defect in C. elegans that is marked by an abnormal globular morphology of the nucleolus and fewer germ cells. We identified DCAF-1 as the CRL4 substrate receptor that ensures proper germ cell nucleolus morphology. We demonstrate that the dcaf-1 gene is the ncl-2 (abnormal nucleoli) gene, whose molecular identity was not previously known...
July 12, 2023: Genetics
https://read.qxmd.com/read/37350740/discovery-of-a-novel-dcaf1-ligand-using-a-drug-target-interaction-prediction-model-generalizing-machine-learning-to-new-drug-targets
#9
JOURNAL ARTICLE
Serah W Kimani, Julie Owen, Stuart R Green, Fengling Li, Yanjun Li, Aiping Dong, Peter J Brown, Suzanne Ackloo, David Kuter, Cindy Yang, Miranda MacAskill, Stephen Scott MacKinnon, Cheryl H Arrowsmith, Matthieu Schapira, Vijay Shahani, Levon Halabelian
DCAF1 functions as a substrate recruitment subunit for the RING-type CRL4DCAF1 and the HECT family EDVPDCAF1 E3 ubiquitin ligases. The WDR domain of DCAF1 serves as a binding platform for substrate proteins and is also targeted by HIV and SIV lentiviral adaptors to induce the ubiquitination and proteasomal degradation of antiviral host factors. It is therefore attractive both as a potential therapeutic target for the development of chemical inhibitors and as an E3 ligase that could be recruited by novel PROTACs for targeted protein degradation...
June 23, 2023: Journal of Chemical Information and Modeling
https://read.qxmd.com/read/37293029/dcaf1-vprbp-triggers-melanomagenic-gene-silencing-through-histone-h2a-phosphorylation
#10
Yonghwan Shin, Sungmin Kim, Gangning Liang, Tobias S Ulmer, Woojin An
DCAF1, also known as VprBP, is a recently identified atypical kinase and plays an important role in downregulating the transcription of tumor suppressor genes as well as increasing the risk for colon and prostate cancers. Melanoma is the most aggressive form of skin cancer arising from pigment-producing melanocytes and is often associated with dysregulation of epigenetic factors targeting histones. Here we demonstrate that DCAF1 is highly expressed and phosphorylates threonine 120 (T120) on histone H2A to drive transcriptional inactivation of growth regulatory genes in melanoma cells...
May 25, 2023: Research Square
https://read.qxmd.com/read/37292767/hiv-1-vpr-induced-dna-damage-activates-nf-%C3%AE%C2%BAb-independent-of-cell-cycle-arrest-and-crl4a-dcaf1-engagement
#11
Carina Sandoval, Oliver I Fregoso
Lentiviral accessory genes enhance replication through diverse mechanisms. HIV-1 accessory protein Vpr modulates the host DNA damage response (DDR) at multiple steps through the degradation of host proteins, cell cycle arrest, DNA damage, and both activation and repression of DDR signaling. Vpr also alters host and viral transcription; however, the connection between Vpr-mediated DDR modulation and transcriptional activation remains unclear. Here, we determined the cellular consequences of Vpr-induced DNA damage using Vpr mutants that allow us to separate the ability of Vpr to induce DNA damage from CRL4A DCAF1 complex dependent phenotypes including cell cycle arrest, host protein degradation, and repression of DDR...
May 23, 2023: bioRxiv
https://read.qxmd.com/read/37268298/correction-to-targeted-protein-degradation-by-electrophilic-protacs-that-stereoselectively-and-site-specifically-engage-dcaf1
#12
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, Minoru Yokoyama, Sofia Banchenko, David Schwefel, Bruno Melillo, Stuart L Schreiber, Xiaoyu Zhang, Benjamin F Cravatt
No abstract text is available yet for this article.
June 2, 2023: Journal of the American Chemical Society
https://read.qxmd.com/read/37069142/phosphorylation-and-stabilization-of-ezh2-by-dcaf1-vprbp-trigger-aberrant-gene-silencing-in-colon-cancer
#13
JOURNAL ARTICLE
Nikhil B Ghate, Sungmin Kim, Yonghwan Shin, Jinman Kim, Michael Doche, Scott Valena, Alan Situ, Sangnam Kim, Suhn K Rhie, Heinz-Josef Lenz, Tobias S Ulmer, Shannon M Mumenthaler, Woojin An
Our recent work has shown that DCAF1 (also known as VprBP) is overexpressed in colon cancer and phosphorylates histone H2AT120 to drive epigenetic gene inactivation and oncogenic transformation. We have extended these observations by investigating whether DCAF1 also phosphorylates non-histone proteins as an additional mechanism linking its kinase activity to colon cancer development. We now demonstrate that DCAF1 phosphorylates EZH2 at T367 to augment its nuclear stabilization and enzymatic activity in colon cancer cells...
April 17, 2023: Nature Communications
https://read.qxmd.com/read/37041410/vprbp-dcaf1-regulates-p53-function-and-stability-through-site-specific-phosphorylation
#14
JOURNAL ARTICLE
Nikhil Baban Ghate, Sungmin Kim, Roasa Mehmood, Yonghwan Shin, Kyunghwan Kim, Woojin An
VprBP (also known as DCAF1) is a recently identified kinase that is overexpressed in cancer cells and serves as a major determinant for epigenetic gene silencing and tumorigenesis. The role of VprBP in driving target gene inactivation has been largely attributed to its ability to mediate histone H2A phosphorylation. However, whether VprBP also phosphorylates non-histone proteins and whether these phosphorylation events drive oncogenic signaling pathways have not been explored. Here we report that serine 367 phosphorylation (S367p) of p53 by VprBP is a key player in attenuating p53 transcriptional and growth suppressive activities...
April 2023: Oncogene
https://read.qxmd.com/read/36948210/discovery-of-nanomolar-dcaf1-small-molecule-ligands
#15
JOURNAL ARTICLE
Alice Shi Ming Li, Serah Kimani, Brian Wilson, Mahmoud Noureldin, Héctor González-Álvarez, Ahmed Mamai, Laurent Hoffer, John P Guilinger, Ying Zhang, Moritz von Rechenberg, Jeremy S Disch, Christopher J Mulhern, Belinda L Slakman, John W Cuozzo, Aiping Dong, Gennady Poda, Mohammed Mohammed, Punit Saraon, Manish Mittal, Pratik Modh, Vaibhavi Rathod, Bhashant Patel, Suzanne Ackloo, Vijayaratnam Santhakumar, Magdalena M Szewczyk, Dalia Barsyte-Lovejoy, Cheryl H Arrowsmith, Richard Marcellus, Marie-Aude Guié, Anthony D Keefe, Peter J Brown, Levon Halabelian, Rima Al-Awar, Masoud Vedadi
DCAF1 is a substrate receptor of two distinct E3 ligases (CRL4DCAF1 and EDVP), plays a critical physiological role in protein degradation, and is considered a drug target for various cancers. Antagonists of DCAF1 could be used toward the development of therapeutics for cancers and viral treatments. We used the WDR domain of DCAF1 to screen a 114-billion-compound DNA encoded library (DEL) and identified candidate compounds using similarity search and machine learning. This led to the discovery of a compound (Z1391232269) with an SPR K D of 11 μM...
March 22, 2023: Journal of Medicinal Chemistry
https://read.qxmd.com/read/36749583/akt-phosphorylates-fam13a-and-promotes-its-degradation-via-cul4a-ddb1-dcaf1-e3-complex
#16
JOURNAL ARTICLE
Lu Gong, Samuel Bates, Yujun Li, Xin Lin, Wenyi Wei, Xiaobo Zhou
Single-nucleotide polymorphisms (SNPs) within FAM13A gene are significantly associated with chronic obstructive pulmonary disease (COPD) and lung function in genome-wide association studies (GWAS). However, how FAM13A protein is regulated under physiological and pathological condition remains largely elusive. Herein, we report that FAM13A is phosphorylated at the Serine 312 residue by AKT kinase after cigarette smoke extract treatment and thereby recognized by the CULLIN4A/DCAF1 E3 ligase complex, rendering the ubiquitination-mediated degradation of FAM13A...
February 7, 2023: American Journal of Respiratory Cell and Molecular Biology
https://read.qxmd.com/read/36278853/the-crl4-e3-ligase-mahjong-dcaf1-controls-cell-competition-through-the-transcription-factor-xrp1-independently-of-polarity-genes
#17
JOURNAL ARTICLE
Amit Kumar, Nicholas E Baker
Cell competition, the elimination of cells surrounded by more fit neighbors, is proposed to suppress tumorigenesis. Mahjong (Mahj), a ubiquitin E3 ligase substrate receptor, has been thought to mediate competition of cells mutated for lethal giant larvae (lgl), a neoplastic tumor suppressor that defines apical-basal polarity of epithelial cells. Here, we show that Drosophila cells mutated for mahjong, but not for lgl [l(2)gl], are competed because they express the bZip-domain transcription factor Xrp1, already known to eliminate cells heterozygous for ribosomal protein gene mutations (Rp/+ cells)...
November 15, 2022: Development
https://read.qxmd.com/read/36170674/targeted-protein-degradation-by-electrophilic-protacs-that-stereoselectively-and-site-specifically-engage-dcaf1
#18
JOURNAL ARTICLE
Yongfeng Tao, David Remillard, Ekaterina V Vinogradova, Minoru Yokoyama, Sofia Banchenko, David Schwefel, Bruno Melillo, Stuart L Schreiber, Xiaoyu Zhang, Benjamin F Cravatt
Targeted protein degradation induced by heterobifunctional compounds and molecular glues presents an exciting avenue for chemical probe and drug discovery. To date, small-molecule ligands have been discovered for only a limited number of E3 ligases, which is an important limiting factor for realizing the full potential of targeted protein degradation. We report herein the discovery by chemical proteomics of azetidine acrylamides that stereoselectively and site-specifically react with a cysteine (C1113) in the E3 ligase substrate receptor DCAF1...
October 12, 2022: Journal of the American Chemical Society
https://read.qxmd.com/read/36055411/dcaf1-inhibits-the-nf-%C3%AE%C2%BAb-pathway-by-targeting-p65
#19
JOURNAL ARTICLE
Fang Huang, Weitong Yao, Binlian Sun, Koh Fujinaga
DCAF1 is considered to be a general substrate-recognizing subunit of E3 ligases, it has been implicated to be directly involved in different cellular processes. DCAF1 is also defined as a constitutive binding partner of viral protein R (Vpr) of the human immunodeficiency virus type 1 (HIV-1) and is essential for functions of Vpr. Here, we revealed that activation of NF-κB by virion-associated Vpr proteins highly depends on DCAF1, and that exogenous DCAF1 is capable of restraining NF-κB induction by external stimuli...
August 30, 2022: Immunology Letters
https://read.qxmd.com/read/35938868/insight-into-viral-hijacking-of-crl4-ubiquitin-ligase-through-structural-analysis-of-the-pul145-ddb1-complex
#20
JOURNAL ARTICLE
Elizaveta T Wick, Colton J Treadway, Zhijun Li, Nathan I Nicely, Zhizhong Ren, Albert S Baldwin, Yue Xiong, Joseph S Harrison, Nicholas G Brown
Viruses evolve mechanisms to exploit cellular pathways that increase viral fitness, e.g., enhance viral replication or evade the host cell immune response. The ubiquitin-proteosome system, a fundamental pathway-regulating protein fate in eukaryotes, is hijacked by all seven classes of viruses. Members of the Cullin-RING family of ubiquitin (Ub) ligases are frequently co-opted by divergent viruses because they can target a broad array of substrates by forming multisubunit assemblies comprised of a variety of adapters and substrate receptors...
August 8, 2022: Journal of Virology
keyword
keyword
33180
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.